The question of whether Mondelez can reach $75 matters because it sits just above the stock's 52-week high of $66.65 and near the upper boundary of Wall Street's published forecasts. It is not an arbitrary figure: several firms have targets clustered around this zone, including a $74 objective from Bernstein, while the highest published target on some platforms reaches $77. For a stock that has spent much of the past year trading between the mid-$50s and mid-$60s, $75 represents both a psychological round-number milestone and a test of whether the market is willing to price in a full earnings recovery.
Mondelez is one of the world's largest pure-play snacking companies, formed in 2012 when the former Kraft Foods split its global snack business from its North American grocery operations. Its portfolio includes iconic brands such as Oreo, Cadbury, Chips Ahoy, Milka, Toblerone, and Halls. Roughly 40% of revenue comes from Europe, about one-third from developing markets, and more than a quarter from North America. This global footprint matters for the $75 debate because it diversifies the company's growth engines while also exposing it to currency swings and regional demand trends.
Mondelez carries a market capitalization near $78.6 billion and trades at a price-to-earnings (P/E) ratio in the low 20s, with a dividend yield around 3.4%. The company recently raised its quarterly dividend from $0.50 to $0.52 per share. Institutional investors own more than 78% of shares outstanding, and the stock has a beta of roughly 0.4, meaning it tends to be less volatile than the broader market. Its latest quarterly results beat expectations, with adjusted earnings per share (EPS) of $0.73 versus a $0.68 consensus and revenue up about 4.1% year over year.
The central bullish argument is a margin recovery driven by falling cocoa costs. Elevated cocoa prices have compressed earnings over the past two years, but management and analysts expect that headwind to begin normalizing in the second half of 2026 and into 2027. A successful unwind of those cost pressures, combined with pricing discipline and continued strength in emerging markets—where organic growth has outpaced developed regions—could reaccelerate EPS growth and justify a higher valuation multiple.
On the technical side, a decisive close above the 52-week high near $66.65 would signal a potential breakout from the stock's long trading range. In that scenario, the next meaningful objective would be the $70–$75 zone, which corresponds to the highest analyst targets and prior supply areas. Durable support sits closer to the $57–$60 range, an area that has repeatedly absorbed selling pressure over the past year.
Several obstacles stand between the current price and $75. North America has been a weak spot, with organic sales declining modestly in fiscal 2025 as budget-conscious consumers pull back. The company's own 2026 guidance projects organic net revenue growth of only flat to 2%, a modest trajectory that limits how quickly earnings can compound. Elevated cocoa costs remain a near-term burden, and competition from peers such as HSY (The Hershey Company) keeps pricing power in check across the chocolate category. If input costs stay high longer than expected or consumer demand weakens further, the earnings multiple may not expand enough to support a $75 valuation.
Brokerages covering Mondelez have generally assigned a "Moderate Buy" or "Strong Buy" consensus rating. The average 12-month price target sits near $67–$69, with notable recent targets including JPMorgan at $72, Morgan Stanley at $71, Jefferies at $73, and Bernstein at $74. Notably, no major firm has a Sell rating, but the spread between the low targets near $63 and the high targets near $77 illustrates genuine disagreement about the pace of recovery. A $75 price would sit at the upper end of this range, meaning the stock would need to outperform even the more optimistic analysts' base-case scenarios.
For traders looking to monitor changing conditions in real time, Tickeron's AI Daily Buy/Sell Signals provide an AI-driven layer of market analysis. The product uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-powered pattern recognition. Traders can use these signals to discover new opportunities, track existing positions, and identify emerging trends more efficiently than manual scanning alone would allow. Exploring these signals can complement your own research as you evaluate the outlook for MDLZ.
A move to $75 is realistic over a longer horizon but is not supported by current full-year guidance alone. The most credible path requires cocoa costs to normalize, emerging-market growth to remain robust, and North American volumes to stabilize—conditions that would allow EPS to reaccelerate and the market to assign a higher multiple. The primary risks are persistent input-cost inflation, softer consumer spending, and the stock's failure to clear resistance near its 52-week high of $66.65. Investors should monitor cocoa price trends, quarterly organic growth rates, and any revisions to analyst targets, as these will signal whether the $75 objective is moving closer or further away.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MDLZ has been loosely correlated with GIS. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if MDLZ jumps, then GIS could also see price increases.
| Ticker / NAME | Correlation To MDLZ | 1D Price Change % | ||
|---|---|---|---|---|
| MDLZ | 100% | -0.46% | ||
| GIS - MDLZ | 65% Loosely correlated | +0.30% | ||
| CAG - MDLZ | 59% Loosely correlated | +1.56% | ||
| CPB - MDLZ | 58% Loosely correlated | +0.52% | ||
| KHC - MDLZ | 58% Loosely correlated | +1.77% | ||
| MKC - MDLZ | 58% Loosely correlated | -1.05% | ||
More | ||||